Clinical Trial Update: Rifaximin Versus Lactulose in Renal Failure [Phase 4]

View source ↗

Summary

Phase 4 trial comparing rifaximin to lactulose in patients with liver cirrhosis and renal failure was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Renal Failure

Drugs mentioned

• LACTULOSE (Lactulose)
• Rifaximin (rifaximin)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Liver Cirrhosis, Renal Failure | Phase 4 | Status: WITHDRAWN